Physiological Barriers
Physiological Barriers - Related Videos
01:25
Physiological Barriers
0 Views •
2023
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers. The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
06:01
Testing the Physiological Barriers to Viral Transmission in Aphids Using Microinjection
0 Views •
Cited by 7 •
2008
Aphids are effective transmitters of plant viruses. Aphid microinjection of virus, the procedure we will show you today, is a technique allowing researchers to inject virus directly into the hemocoel of the aphid, bypassing the gut, one of the 2 major barriers for virus transmission in a circulative manner. The same technique is also used to inject dsRNA for RNAi.
01:23
Factors Affecting Drug Distribution: Physiological Barriers
0 Views •
2025
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers. The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream. The...
05:33
Physiology of the Circulatory System - Concepts
0 Views •
2019
Homeostasis Conditions in the external environment of an organism can change rapidly and drastically. To survive, organisms must maintain a fairly constant internal environment, which involves continuous regulation of temperature, pH, and other factors. This balanced state is known as homeostasis, which describes the processes by which organisms maintain their optimal internal conditions. To maintain homeostasis, organisms have developed structures with distinct functions. Physiology is the...
09:23
Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells
0 Views •
Cited by 31 •
2017
The aim of the protocol is to present an optimized procedure for the establishment of an in vitro blood-brain barrier (BBB) model based on primary porcine brain endothelial cells (pBECs). The model shows high reproducibility, high tightness, and is suitable for studies of transport and intracellular trafficking in drug discovery.
FAQs
Tight junctions limit movement between neighboring cells, while selectively permeable membranes control which substances cross the cells themselves. Together, they help separate body compartments and regulate exposure to internal tissues. This coordinated control allows essential nutrients, gases, and signals to pass while restricting pathogens and harmful molecules, making barrier selectivity central to tissue protection.
These components provide complementary forms of control. Mucus layers create a protective interface, metabolic enzymes can act on substances encountered at the barrier, and regulated transporters influence which molecules enter or leave a compartment. Their combined activity determines not only physical passage but also the chemical exposure of underlying tissues.
Changes in permeability can alter the movement of pathogens, harmful molecules, nutrients, gases, signals, or medicines between compartments. When barrier control is disrupted, tissues may experience abnormal exposure and disease processes may develop or worsen. For clinical research, examining permeability helps connect barrier dysfunction with infection, inflammation, toxicity, and treatment response.
The blood-brain, intestinal, skin, and placental barriers use barrier features and transport controls in different tissue settings. Consequently, a substance that reaches one compartment may be restricted in another, or may encounter different protective processes. Comparing these barriers helps researchers interpret tissue-specific disease mechanisms and anticipate challenges in delivering medicines to selected targets.
Researchers examine barrier properties to determine whether a medicine can reach its intended target without producing unwanted exposure elsewhere. Membrane selectivity, tight junctions, mucus, metabolic enzymes, and transporters can each influence this outcome. Barrier-focused research therefore supports the design and evaluation of treatments whose effectiveness depends on access to particular body compartments.
Barrier integrity research addresses how infections, inflammation, toxicity, and other disorders affect tissue protection and substance movement. It can also clarify why a treatment succeeds or fails when its target lies behind a physiological barrier. In clinical science, these findings connect structural and functional barrier changes with disease development and therapeutic strategies.
These barriers represent distinct sites where controlled exchange influences health and treatment. Studying them helps researchers investigate how pathogens or harmful molecules reach vulnerable tissues, how nutrients and signals are regulated, and how medicines encounter access limitations. Their comparison provides context for understanding barrier-specific disease mechanisms, toxicity concerns, and delivery problems.
Such studies can reveal whether a barrier remains protective, becomes abnormally permeable, or restricts delivery of a needed medicine. They also help relate barrier behavior to infection, inflammation, toxicity, and disorders involving barrier dysfunction. These outcomes support the development and assessment of treatments by identifying how tissue access and protection influence clinical relevance.